betamethasone 21-valerate,
betamethasone 21-valerate, (11beta,16beta)-isomer,
Betamethasone 21-valerate,
UNII-BW52JZ3627,
2240-28-0,
BW52JZ3627,
[2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] pentanoate,
Betamethasone-21-valerate,
betamethasonvalerat,
Betamethasone 21-valerate (beta),
AC1L3P44,
SCHEMBL18879710,
Betamethasone impurity E (PhEur),
ZINC31333842,
AKOS034834103,
API0006586,
Betamethasone Related Compound A (USP),
Betamethasone 21-valerate, pharmaceutical impurity standard,
Betamethasone 21-valerate, European Pharmacopoeia (EP) Reference Standard,
9-Fluoro-11beta,17-dihydroxy-16beta-methyl-3,20-dioxopregna-1,4-dien-21-yl Pentanoate (Betamethasone 21-Valerate),
Betamethasone Valerate Related Compound A, United States Pharmacopeia (USP) Reference Standard,
Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-16-methyl-21-((1-oxopentyl)oxy)-, (11beta,16beta)-,
Pregna-1,4-diene-3,20-dione, 9-fluoro-11beta,17-dihydroxy-16beta-methyl-21-((1-oxopentyl)oxy)-,
Dexamethasone valerate,
CID92922,
AR-1L1759,
Betamethasone Valerate EP Impurity E,
C27-H37-F-O6,
CS-O-06191,
32588-74-2,
Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-16-methyl-21-[(1-oxopentyl)oxy]-, (11.beta.,16.beta.)-,
pregna-1,4-diene-3,20-dione, 9-fluoro-11|A,17-dihydroxy-16|A-methyl-21-((1-oxopentyl)oxy)-,